deltatrials
Completed PHASE2/PHASE3 INTERVENTIONAL NCT00164372

Behavioral Intervention for HIV and HCV-Uninfected Injection Drug Users

Collaborative Injection Drug Users Study III/Drug Users Intervention Trial (CIDUS III/DUIT)

Sponsor: Centers for Disease Control and Prevention

Updated 5 times since 2017 Last updated: Sep 26, 2012 Started: May 31, 2002 Primary completion: Dec 31, 2006 Completion: Dec 31, 2006
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00164372, this PHASE2/PHASE3 trial focuses on HIV Infections and Hepatitis C and remains completed. Sponsored by Centers for Disease Control and Prevention, it has been updated 5 times since 2002, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2/PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2/PHASE3

    Phase: PHASE2_PHASE3PHASE2/PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2_PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2_PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE2_PHASE3

    First recorded

May 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centers for Disease Control and Prevention
Data source: Centers for Disease Control and Prevention

For direct contact, visit the study record on ClinicalTrials.gov .